COUR Pharmaceuticals Appoints Paul M. Peloso, MD, as Chief Medical Officer … [Read more...] about COUR Pharmaceuticals Appoints Paul M. Peloso, MD, as Chief Medical Officer
COUR Pharmaceuticals Secures $105 Million in Series A Financing Co-Led by Lumira Ventures and Alpha Wave Ventures … [Read more...] about COUR Pharmaceuticals Secures $105 Million in Series A Financing Co-Led by Lumira Ventures and Alpha Wave Ventures
COUR Pharmaceuticals Appoints Dannielle Appelhans as Chief Operating Officer … [Read more...] about COUR Pharmaceuticals Appoints Dannielle Appelhans as Chief Operating Officer
COUR Pharmaceuticals Announces Biotechnology Industry Veteran Robert F. Carey Joins Board of Directors as Lead Independent Director … [Read more...] about COUR Pharmaceuticals Announces Biotechnology Industry Veteran Robert F. Carey Joins Board of Directors as Lead Independent Director
COUR Pharmaceuticals Announces FDA Clearance of Investigational New Drug Application for Myasthenia Gravis … [Read more...] about COUR Pharmaceuticals Announces FDA Clearance of Investigational New Drug Application for Myasthenia Gravis
